Product Images Stivarga
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Stivarga NDC 50419-171 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Main Display Panel Commercial Carton 40 mg - image 01
Description: Chemical Structure - image 02
Stivarga GIST USPI Figure 1 v3 - image 03
This appears to be a graph or data table that shows the survival probability for patients who received Stivarga versus placebo over time. The x-axis represents months from randomization and the y-axis represents survival probability as a percentage. There are two lines on the graph, one for Stivarga and one for placebo, and they intersect at around 8 months. The data is broken down by the number of patients at risk for each treatment group at each time point.*
Stivarga GIST USPI Figure 2 v3 - image 04
This table shows the probability of progression-free survival for patients receiving Stivarga compared to those receiving a placebo. The percentage of progression-free survival is 100%, and the number of patients at risk is shown for each group (Stivarga and Placebo). The table also includes the number of patients in each group (133 for Stivarga and 66 for Placebo).*
Fig 3 Curve of Overall Survival - image 05
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.